Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-31

FDA Approved: DILAUDID — Supplemental Application (Rhodes Pharmaceuticals L.P.)

View source ↗

Summary

FDA approved a supplemental application for DILAUDID (hydromorphone hydrochloride) filed by Rhodes Pharmaceuticals L.P.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DILAUDID (Hydromorphone hydrochloride)

Snippet

SUPPL AP for DILAUDID (HYDROMORPHONE HYDROCHLORIDE)